Medicine, Endocrinology, Biochemistry, and Molecular Biology, Pharmacology
Under a Creative Commons license
Open access
Wound healing is a complex process involving various cellular and molecular events aimed at restoring tissue integrity. Growth factors play a pivotal role in orchestrating these events by regulating cell migration, proliferation, differentiation, and extracellular matrix synthesis. Several growth factors have been identified as crucial mediators of wound healing, including PDGF, TGF-β, VEGF, FGF, and EGF. PDGF is released by platelets upon injury and stimulates the migration and proliferation of fibroblasts and smooth muscle cells, promoting the formation of granulation tissue. TGF-β regulates various aspects of wound healing, including inflammation, collagen deposition, and tissue remodeling. VEGF promotes angiogenesis, facilitating the formation of new blood vessels to supply oxygen and nutrients to the healing tissue. FGF stimulates fibroblast proliferation and angiogenesis, contributing to tissue regeneration. EGF promotes the migration and proliferation of epithelial cells, aiding in the re-epithelialization of the wound. These growth factors act in a coordinated manner to promote each phase of wound healing, including hemostasis, inflammation, proliferation, and remodeling. Dysregulation of growth factor expression or signaling can impair the healing process, leading to chronic wounds or excessive scar formation. Understanding the roles of growth factors in wound healing has led to the development of therapeutic strategies aimed at enhancing wound repair.
Growth factors
wound healing
PDGF
TGF-β
VEGF
FGF
EGF
tissue repair
Wound healing is a complex process involving hemostasis, inflammation, proliferation, and remodeling, regulated by various growth factors. Problems arise when these factors are imbalanced or deficient. Key growth factors include PDGF (promotes fibroblast function), TGF-β (modulates inflammation and collagen production), EGF (supports re-epithelialization), VEGF (stimulates angiogenesis), FGF (aids cell proliferation), IGF (collagen synthesis), KGF (keratinocyte proliferation), and TNF-α (inflammation control). Factors contributing to imbalance include diabetes, chronic inflammation, aging, nutritional deficiencies, hypoxia, and certain medications. Addressing these imbalances is crucial for managing chronic and difficult-to-heal wounds. Factors responsible for wound healing refer to the coordinated and regulated action of several growth factors, cytokines, and signaling molecules, which are essential for the complex process of wound healing. These substances are vital for the several phases of wound healing, including tissue remodeling, proliferation, and inflammation. These are the primary variables that contribute to the growth and healing of wounds. The correlation between these growth factors highlights their interconnected roles in wound healing. PDGF initiates the recruitment of key cells to the wound site, while TGF-β regulates the transition from inflammation to tissue formation. VEGF ensures that newly forming tissue receives an adequate blood supply, and FGFs enhance the production of the ECM and facilitate cellular proliferation. EGF supports the final stages of wound closure and skin restoration. The synchronized action of these growth factors ensures that wound healing proceeds through the necessary stages of inflammation, proliferation, and remodeling. Essential roles and therapeutic interventions aimed at modulating growth factor activity hold significant potential. Recombinant growth factors, such as PDGF and EGF, have been developed to enhance wound healing in clinical settings, particularly for chronic wounds like diabetic ulcers. Growth factor-containing dressings, which provide a sustained release of these molecules to the wound site, have also shown promise in promoting faster and more effective healing. Additionally, gene therapy approaches that target growth factor signaling pathways could provide more precise and long-lasting interventions for tissue repair.
Platelet-derived growth factor (PDGF) is a hormone that can cause the proliferation of vascular endothelial cells, vascular smooth muscle fibers, and fibroblasts to help repair damaged blood vessel walls. Multiple cell types proliferation, differentiation, and activation are regulated by the polypeptide cytokine PDGF. First identified as a platelet-derived growth factor that selectively activates soft tissue and mesenchymal fibroblasts, platelet-derived growth factor isoforms are released by stimulated cells, including macrophages, fibroblasts, and endothelial cells. Numerous wound healing processes, including soft tissue repair, bone repair, and epithelial regeneration, are aided by these isoforms. A further synergistic interaction between PDGF and other growth factors might be the source of some of these actions. The growth factors IGF, FGF, TGF-α, and epidermal growth factor (EGF) are involved in tissue healing. All these growth factors, such as PDGF, belong to distinct families of molecules with similar roles. The growth factors that have been discovered seem to interact in complex and mostly unexamined ways to alter vital physiological processes, including morphogenesis, adult stem cell commitment, wound healing, and embryogenesis. A recent investigation into the potential significance of PDGF in pathological circumstances such as atherosclerosis and autoimmune diseases, as well as normal metabolic working properly, has been launched. PDGFs or platelet-derived growth factors include both small and large substances, such as proteins and hormones. Platelet-derived growth factors (PDGF) are pleasurable chemicals that, in the context of wound recovery processes, strengthen cellular proliferation and differentiation, influence the generation of an extracellular matrix, and expedite tissue regeneration and cellular proliferation (Fig. 1). Furthermore, PLT induces keratinocytes to migrate into the wound, resulting in the production of a protective epidermal layer that is caused by its proliferative and cell division-inducing properties. When endothelial damage occurs from close interaction with circulating collagen, platelets, which are ordinarily in a dormant state, become activated. α-granules containing biologically active proteins and PDGF are secreted by activated platelets. These essential elements of hemostasis include leukocyte recruitment, vessel healing, and capillary constriction. PDGF plays a part in all stages of the wound healing process and is mostly produced as a consequence of damage. In acute wounds, it is abundant, but in chronic wounds, it is diminished. By binding to transmembrane tyrosine kinase receptors, particularly PDGF receptor-β, it triggers a sequence of internal events that lead to the activation of certain genes, including c-Fos. Like IL-1, PDGF draws neutrophils to the wound site to eradicate germs. Additionally, TGF-inducing monocytes to become macrophages increases the inflammatory response and facilitates tissue cleansing, epithelial cell regrowth, and tissue reorganization. The proliferation of keratinocytes, cell migration, and the reconstruction of the skins topmost layer are all made possible by EGF, which is essential for the healing of acute wounds. By increasing blood vessel permeability and encouraging the development of new blood vessels (angiogenesis), VEGF speeds up the healing process. CTGF regulates the synthesis of collagen and stimulates angiogenesis, platelet adhesion, and white blood cell motility. The creation and secretion of growth factors by keratinocytes, fibroblasts, and PLT during tissue healing must be emphasized. There are several techniques for creating PC, and each one results in a distinct final product with distinct biological properties, such as different concentrations of growth factors, and possible applications. The lack of consistency and a thorough description of the techniques used makes it difficult to compare the results. When using autologous or allogeneic platelet concentrates, clinicians need to assess the hazards involved, mostly transfusion-transmitted infections. Autologous PLT isolates are recommended by patients since there is no possibility of cross-infection. But in situations when underlying illnesses like cancer, hematologic malignancies, diabetes, etc., may impair the beneficial effects of PC products, it is not recommended. Moreover, there may be differences in quality between autologous preparations of platelet concentrate (PC) and allogeneic preparations from blood banks that meet predetermined standards. Comparing approaches and results is difficult because of this disparity. The use of allogeneic PC has risen because of the significant decrease in viral virus transmission risk caused by the use of NAT in screening blood donors. The crucial role that platelets play is that once platelets are dormant, they circulate the entire body. They are rapidly activated and actively engage in blood clotting and the formation of clots in the bloodstream, whether there is destruction of the vessel walls under certain conditions (like a decrease in nitric oxide levels). In Fig. (2) platelets are rich in mRNA and membrane receptors, which facilitate quick healing. PLT aggregates may form and direct protein synthesis is possible as a consequence. PLT cannot establish enduring associations with endothelial cells under ordinary conditions; nevertheless, on pathological or hyperactive endothelial cells, this phenomenon may transpire as a result of insufficient nitric oxide generation.
Fig. (1). The role of platelet-derived growth factor (PDGF) in the process of repairing injuries. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF), transforming growth factor-β (TGF-β), and fibroblast growth factor (FGF), Platelet Count (PLT) are among the terms used.
Fig. (2). Platelets functional responsibilities (PLT).
The inflammation mechanisms that surround endothelial cells intensify when platelets stick to them. This might eventually result in damage, the formation of plaques, and apoptosis of the endothelial cells. Subendothelial matrix proteins, such as collagens and tissue factors expressed on the membrane surface, are visible in endothelium layer lesions. These amino acids have potent coagulation initiation and platelet activation characteristics. Following a vascular lesion, platelets are initially anchored or trapped by the GPIb-IX-V complex interacting with the von Willebrand factor (VWF). VWF interacts with glycoprotein Ib (GPIb) more readily when it attaches to collagen because it changes its form. This touch is not enough to ensure immediate and lasting adhesion. However, it does so via activating GPVI, a collagen receptor, which in turn activates integrins IIb3 (GPIIb/IIIa) and 21 (GPIa/IIa). The latter molecules form a powerful bond with elastin and VWF/fibrinogen, which activates GPVI. The feedback messengers TxA2 and ADP are eliminated by the platelets as a result of impulses sent out by the two platelet integrins and GPVI. The platelets distribute as well throughout the network. VWF, fibrinogen, ADP, TxA2, and
